Jade Coats, OD: AbbVie/Allergan: Advisory Committee/Board Member (); Alcon: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Bausch + Lomb: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Bausch Health: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Dompe: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Harrow Pharmaceuticals: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Orasis: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Sun Pharma: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Tarsus Pharma: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Tenpoint: Advisory Committee/Board Member (); Thea Pharma: Advisory Committee/Board Member (); ZEISS: Advisory Committee/Board Member (), Consulting Fees ()
This course reviews the latest innovations in diagnostic tools, imaging, and technology transforming optometric practices. Key topics include corneal and ocular surface assessment, color vision and genetic testing, binocular vision evaluation, glaucoma monitoring, contact lens advancements, and pre- and post-operative care for refractive and presbyopia-correcting IOLs. Attendees will gain practical strategies for integrating emerging diagnostics, biomarkers, and therapeutic technologies into clinical practice to improve patient outcomes, streamline care, and support evidence-based decision-making.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Review current and emerging diagnostic tools for corneal, ocular surface, and binocular vision disorders, including color vision testing, corneal sensitivity measurement, and point-of-care inflammatory markers.
Evaluate innovations in glaucoma diagnostics, including portable visual fields, ERG, tonometry, and genetic risk assessment, and their implications for early detection and management.
Analyze advances in pre- and post-operative care for refractive surgery and presbyopia-correcting IOLs, including co-management strategies and novel diagnostic technologies.
Integrate new diagnostic and therapeutic approaches for ocular surface, blepharitis, MGD, and Demodex, including IPL, thermal devices, and pharmacologic options, into clinical practice.
Apply clinical case-based reasoning to select appropriate diagnostic modalities and implement technology-driven care to improve patient outcomes and practice efficiency.
